Craft

Daewoong Pharmaceutical

Stock Price

₩150.4 K

2024-10-29

Market Capitalization

₩1.7 T

2024-10-29

Revenue

₩2.1 T

FY, 2025

Daewoong Pharmaceutical Summary

Company Summary

Overview
Daewoong Pharmaceutical (대웅제약) is a company that provides pharmaceutical solutions and services. It offers products in areas such as endocrinology, central nervous system, musculoskeletal, nephrology, antineoplastic, cardiovascular, etc. The company caters to the healthcare industry.
Type
Public
Status
Active
Founded
2002
HQ
Seoul, KR | view all locations
Website
https://www.daewoong.co.kr/en/main/index
Cybersecurity rating
Sectors

Key People

  • Chang-jae Lee

    Chang-jae Lee, CEO

    • Seongsoo Park
    • Eunkyeong Park, Executive Director

      • Youngmin Cho, Outside Director

        LocationsView all

        4 locations detected

        • Seoul, Seoul HQ

          Korea (Republic of)

          12, Bongeunsan-ro 114-gil, Gangnam-gu

        • Hyderabad, TG

          India

          Plot No. 5A, APIIC, IE, Prashanth Nagar, Kukatpally

        • Taguig City, NCR

          Philippines

          One World Place, 9th Ave

        • Bangkok, Krung Thep Maha Nakhon

          Thailand

          1550 Thanapoom Tower, New Petchburi Road

        Daewoong Pharmaceutical Financials

        Summary Financials

        Revenue (Q1, 2026)
        ₩492.7B
        Gross profit (Q1, 2026)
        ₩281.3B
        Net income (Q1, 2026)
        ₩53.3B
        Cash (Q1, 2026)
        ₩259.7B
        EBIT (Q1, 2026)
        ₩43.6B
        Enterprise value
        $2.4T

        Footer menu